Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study

BACKGROUND: This phase II bridging study assessed the safety and efficacy of nab-paclitaxel/gemcitabine (Metastatic Pancreatic Adenocarcinoma Clinical Trial [MPACT] regimen) in Chinese patients with metastatic pancreatic cancer (MPC). METHODS: This 3-part sequential study evaluated nab-paclitaxel 12...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Xu, Ruihua, Yu, Xianjun, Hao, Jihui, Wang, Liwei, Pan, Hongming, Han, Guohong, Xu, Jianming, Zhang, Yanqiao, Yang, Shujun, Chen, Jia, Ying, Jieer, Dai, Guanghai, Li, Mingyu, Begic, Damir, Lu, Brian, Shen, Lin
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740894/
https://ncbi.nlm.nih.gov/pubmed/29273007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3887-z
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares